Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 35

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 35
---
 10.40^
     
    Amendment No. 1 to License Agreement between Sarepta Therapeutics, Inc. and ST International Holdings Two, Inc. on the one hand and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMarin Technologies BV on the other hand
     
    10-Q
     
    001-14895
     
    10.1
     
    8/7/19

     10.41†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. Amended and Restated 2013 Employment Stock Purchase Plan (as Amended and Restated on June 27, 2016)
     
    10-Q
     
    001-14895
     
    10.4
     
    8/7/19

     10.42
     
    Letter Agreement between Sarepta Therapeutics, Inc. and Myonexus Therapeutics, Inc. dated February 26, 2019
     
    10-Q
     
    001-14895
     
    10.1
     
    5/8/19

     10.43†
     
    Form of Executive Vice President Severance Letter Agreement
     
    10-Q
     
    001-14895
     
    10.2
     
    5/8/19

     10.44†
     
    Form of Executive Vice President Change in Control and Severance Agreement 
     
    10-Q
     
    001-14895
     
    10.3
     
    5/8/19

     10.45^
     
    License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21, 2019
     
    10-K
     
     001-14895
     
    10.51
     
    2/26/20

     10.46†
     
    Director Compensation Policy
     
    10-K
     
     001-14895
     
    10.55
     
    2/26/20

     10.47†
     
    Amendment No. 2 to the S